Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial

• Main Authors: M. Golembo (Author), S. Puttagunta (Author), U. Rappo (Author), E. Weinstock (Author), R. Engelstein (Author), I. Gahali‐Sass (Author), A. Moses (Author), E. Kario (Author), E. Ben‐Dor Cohen (Author), J. Nicenboim (Author), H. Ben David (Author), K. Sudakov (Author), A. Cohen (Author), M. Bassan (Author), N. B. Zak (Author)
• Format: Book
• Published: Wiley, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Topical antibiotics are frequently used to treat acne vulgaris. Their prolonged use, often for longer durations than recommended, has led to antibiotic resistance in Cutibacterium acnes (C. acnes), a bacterium implicated in acne pathophysiology. Bacteriophage (phage), which speci...